Astonea Labs Resubmits FY25 Financial Results Rectifying Regulatory Discrepancies
Astonea Labs Ltd · Financial Result · 19 Sept 2026, 5:11 pm
Astonea Labs Resubmits FY25 Financial Results Rectifying Regulatory Discrepancies Astonea Labs Limited resubmitted its standalone audited financial results and unmodified auditor's report for the fiscal year ended 31st Mar'25 to rectify BSE filing discrepancies. The company clarified that results previously submitted in XBRL mode on 11th Jul'25 omitted the separate PDF format and Regulation 33(3) declaration under corporate announcements. For FY25, revenue from operations grew 21.61% YoY to ₹9,751.83 lakhs compared to ₹8,019.09 lakhs in FY24. Net profit increased 31.46% YoY to ₹535.05 lakhs, with basic and diluted EPS rising to ₹6.94 from ₹5.36.
Original exchange filing (PDF)
More announcements from Astonea Labs Ltd
- Non-Applicability of Statement of Deviation & Variation for the half year ended 30th September, 2026 · 15 Nov 2026
- Revised Outcome of Board Meeting held on 14th November, 2026 · 15 Nov 2026
- Unaudited Financial Results (Standalone & Consolidated) for the half year ended 30th September, 2026 · 14 Nov 2026
- Outcome of Board Meeting held on 14th November, 2026 · 14 Nov 2026
- Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited Standalone and Consolidated .... · 14 Nov 2026
- Please find enclosed herewith an Intimation regarding change in the Corporate Identification Number (CIN) of the Company consequent upon alteration of the Object Clause of the Memorandum .... · 09 Oct 2026
- Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Incorporation of Proposed Subsidiary- Longevity Science Private Limited · 08 Oct 2026
- Please find enclosed herewith re-submission of financial results for the half year and year ended 31.03.2025. · 22 Sept 2026
